Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte. For more information on Jakafi® (ruxolitinib), visit hcp.jakafi.com [hcp.jakafi.com]. For more information on MONJUVI® (tafasitamab-cxix), visit monjuvihcp.com [monjuvihcp.com]. For more information on Pemazyre® (pemigatinib), visit hcp.pemazyre.com [hcp.pemazyre.com].
